Clinical characteristics of patients with Acinetobacterjunii infection

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 1, 2009, Pages 47-53

  Hung, Yu Tse ^a,b   Lee, Yi Tzu ^a   Huang, Ling Ju ^a   Chen, Te Li ^a,c   Yu, Kwok Woon ^a   Fung, Chang Phone ^c,d   Cho, Wen Long ^c   Liu, Cheng Yi ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Chutung Veterans Hospital   (Taiwan)

Author keywords

Acinetobacter; Acinetobacter infections; Disease attributes; Epidemiology

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; RNA 23S; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER INFECTION; ACINETOBACTER JUNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DEATH; DRUG USE; EMPYEMA; FEMALE; GENETIC ANALYSIS; HOSPITAL INFECTION; HUMAN; INFLAMMATION; INVASIVE PROCEDURE; KERATITIS; MALE; NEOPLASM; NONHUMAN; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PERITONITIS; SCHOOL CHILD; SHOCK; TAIWAN;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CHILD; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 67549150618     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kloos WE, Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Microbiol. 1975;30:381-5.
2. Larson EL. Persistent carriage of Gram-negative bacteria on hands. Am J Infect Control. 1981;9:112-9.
3. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997;35:2819-25.
4. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148-65.
5. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis. 2001;32(Suppl 2):S104-13.
6. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control. 1998;26:522-33.
7. Gennari M, Lombardi P. Comparative characterization of Acinetobacter strains isolated from different foods and clinical sources. Zentralbl Bakteriol. 1993;279:553-64.
8. Vaneechoutte M, Elaichouni A, Maquelin K, Claeys G, Van Liedekerke A, Louagie H, et al. Comparison of arbitrarily primed polymerase chain reaction and cell envelope protein electrophoresis for analysis of Acinetobacter baumannii and A. junii outbreaks. Res Microbiol. 1995;146:457-65.
9. Bernards AT, de Beaufort AJ, Dijkshoorn L, van Boven CP. Outbreak of septicaemia in neonates caused by Aci- netobacter junii investigated by amplified ribosomal DNA restriction analysis (ARDRA) and four typing methods. J Hosp Infect. 1997;35:129-40.
10. de Beaufort AJ, Bernards AT, Dijkshoorn L, van Boven CP. Acinetobacter junii causes life-threatening sepsis in preterm infants. Acta Paediatr. 1999;88:772-5.
11. Kappstein I, Grundmann H, Hauer T, Niemeyer C. Aerators as a reservoir of Acinetobacter junii: an outbreak of bacteraemia in paediatric oncology patients. J Hosp Infect. 2000;44:27-30.
12. Linde HJ, Hahn J, Holler E, Reischl U, Lehn N. Septicemia due to Acinetobacter junii. J Clin Microbiol. 2002;40:2696-7.
13. Chang WN, Lu CH, Huang CR, Chuang YC. Community-acquired Acinetobacter meningitis in adults. Infection. 2000; 28:395-7.
14. Borras M, Moreno S, Garcia M, Martin ML, Manonelle A, Fernandez E. Acinetobacter junii causes refractory peritonitis in a patient on automated peritoneal dialysis. Perit Dial Int. 2007;27:101-2.
15. Prashanth K, Ranga MP, Rao VA, Kanungo R. Corneal perforation due to Acinetobacter junii: a case report. Diagn Microbiol Infect Dis. 2000;37:215-7.
16. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, Chang TC. Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol. 2005;43:1632-9.
17. Performance standards for antimicrobial disk susceptibility tests. Approved standard, 9th ed. CLSI document M2-A9. Wayne: Clinical and Laboratory Standards Institute; 2006.
18. Seifert H, Dolzani L, Bressan R, van der Reijden T, van Strijen B, Stefanik D, et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis- generated fingerprints of Acinetobacter baumannii. J Clin Microbiol. 2005;43:4328-35.
19. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55.
20. Carrico R, Ramirez J. A process for analysis of sentinel events due to health care-associated infection. Am J Infect Control. 2007;35:501-7.
21. Allard C, Carignan A, Bergevin M, Boulais I, Tremblay V, Robichaud P, et al. Secular changes in incidence and mortality associated with Staphylococcus aureus bacteraemia in Quebec, Canada, 1991-2005. Clin Microbiol Infect. 2008;14:421-8.
22. Seifert H. Acinetobacter species as a cause of catheter- related infections. Zentralbl Bakteriol. 1995;283:161-8.
23. Seifert H, Strate A, Schulze A, Pulverer G. Bacteremia due to Acinetobacter species other than Acinetobacter baumannii. Infection. 1994;22:379-85.
24. Berlau J, Aucken H, Malnick H, Pitt T. Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Infect Dis. 1999;18:179-83.
25. Chu YW, Leung CM, Houang ET, Ng KC, Leung CB, Leung HY, et al. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol. 1999;37:2962-7.
26. Patil JR, Chopade BA. Distribution and in vitro antimicrobial susceptibility of Acinetobacter species on the skin of healthy humans. Natl Med J India. 2001;14:204-8.
27. Bjornson HS, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery. 1982;92:720-7.
28. Cooper GL, Hopkins CC. Rapid diagnosis of intravascular catheter-associated infection by direct Gram staining of catheter segments. N Engl J Med. 1985;312:1142-7.
29. Cisneros JM, Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8:687-93.
30. Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, García-Garmendía JL, et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis. 1996;22:1026-32.
31. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore). 1995;74:340-9.
32. García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Pérez-Paredes C, Barrero- Almodóvar AE, et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis. 2001;33:939-46.
33. Higgins CS, Murtough SM, Williamson E, Hiom SJ, Payne DJ, Russell AD, et al. Resistance to antibiotics and bio- cides among non-fermenting Gram-negative bacteria. Clin Microbiol Infect. 2001;7:308-15.
34. Marqué S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, et al. Regional occurrence of plasmid-mediated carbapenem- hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol. 2005;43:4885-8.
35. Peleg AY, Franklin C, Walters LJ, Bell JM, Spelman DW. OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob Agents Chemother. 2006;50:399-400.